Suppr超能文献

通气的慢性阻塞性肺疾病(COPD)患者使用一种支气管扩张剂与两种支气管扩张剂的比较。

Comparison of one versus two bronchodilators in ventilated COPD patients.

作者信息

Fernandez A, Muñoz J, de la Calle B, Alia I, Ezpeleta A, de la Cal M A, Reyes A

机构信息

Servicio de Cuidados Intensivos, Hospital Universitario de Getafe, Madrid, Spain.

出版信息

Intensive Care Med. 1994;20(3):199-202. doi: 10.1007/BF01704700.

Abstract

OBJECTIVE

To compare the bronchodilating effect of a single drug, ipratropium bromide (IBr), with that of its combination with fenoterol (IBr+F).

DESIGN

The study was triple blind and randomized.

SETTING

Medical-surgical intensive care unit.

PATIENTS

12 patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation for severe respiratory failure.

INTERVENTIONS

Before administering each drug, peak airway pressure (Ppeak), end inspiratory pressure (Pei), resistive pressure (Pres), and auto positive--end expiratory pressure (auto-PEEP) were measured. Inspiratory system resistance (Rins) and dynamic respiratory system compliance (C) were calculated. Arterial pH and blood gas determinations were made. These measurements were repeated 60 min after administration of each therapeutic regimen. For ipratropium bromide alone the dose was 0.04 mg. When the combination of drugs was used, the doses were 0.04 mg for ipratropium bromide and 0.1 mg for fenoterol.

MEASUREMENTS AND RESULTS

With the combination of both drugs, all the pressures in the airway, as well as the auto-PEEP and the Rins were significantly reduced (p < 0.05) with respect to baseline values. With ipratropium bromide alone, no significant changes were observed either in the pressures or in the inspiratory resistance. No significant changes were observed either in the pH or blood gases with any of the treatments. The combination of both drugs produced significantly reduction in Pei and auto-PEEP when compared with ipratropium bromide alone.

CONCLUSIONS

The combination of both drugs is more effective than ipratropium bromide alone at the doses used in this study.

摘要

目的

比较单一药物异丙托溴铵(IBr)及其与非诺特罗联合使用(IBr + F)的支气管扩张效果。

设计

该研究为三盲随机试验。

地点

内科 - 外科重症监护病房。

患者

12例慢性阻塞性肺疾病(COPD)急性加重且因严重呼吸衰竭需要机械通气的患者。

干预措施

在给予每种药物之前,测量气道峰值压力(Ppeak)、吸气末压力(Pei)、阻力压力(Pres)和内源性呼气末正压(auto - PEEP)。计算吸气系统阻力(Rins)和动态呼吸系统顺应性(C)。进行动脉pH值和血气测定。在给予每种治疗方案60分钟后重复这些测量。单独使用异丙托溴铵时剂量为0.04毫克。当联合使用药物时,异丙托溴铵剂量为0.04毫克,非诺特罗剂量为0.1毫克。

测量与结果

联合使用两种药物时,气道中的所有压力以及auto - PEEP和Rins相对于基线值均显著降低(p < 0.05)。单独使用异丙托溴铵时,压力或吸气阻力均未观察到显著变化。任何一种治疗方法对pH值或血气均未观察到显著变化。与单独使用异丙托溴铵相比,联合使用两种药物可使Pei和auto - PEEP显著降低。

结论

在本研究使用的剂量下,两种药物联合使用比单独使用异丙托溴铵更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验